IPI's Certified Psychedelic-Assisted Therapy Provider
Training Program
Live
Jan 01, 2024
–
Oct 31, 2024
10,000
USD
Online
10 Months
Awarded: Certificate of Completion
Description
The IPI Online Psychedelic-Assisted Therapy Program is a year-long course, taught by more than 30 experts in psychedelic-assisted therapy and research. This program will educate practitioners about the protocols of investigational psychedelic-assisted therapy treatments for PTSD, depression, anxiety, and more. It will also dive into the details of what research and practice have uncovered in the realm of psychedelic sciences, therapeutic processes unique to psychedelic therapy, preparation, dosing, integration, clinic models, and how psychedelics work in combination with other types of therapies.
This 256-hour program was designed from the ground up to be taken online, allowing a busy therapist to take it without traveling.
Participants who attend the in-person psilocybin experiential live portion of the training will be eligible to become an IPI Certified Psychedelic Assisted Therapy Practitioner. If you do not choose the psilocybin in-person experiential option you may still earn these documents upon the successful completion of program requirements, but you will not be eligible for the certification IPI offers. The scope of this certification DOES NOT include the investigational MDMA assisted-therapy protocol, or anything related to MAPS PBC’s educational content. There are no guarantees about FDA approval of MAPS PBC’s New Drug Application for investigational MDMA-assisted therapy or the specific certification requirements for healthcare providers should approval be granted.
This 256-hour program was designed from the ground up to be taken online, allowing a busy therapist to take it without traveling.
Participants who attend the in-person psilocybin experiential live portion of the training will be eligible to become an IPI Certified Psychedelic Assisted Therapy Practitioner. If you do not choose the psilocybin in-person experiential option you may still earn these documents upon the successful completion of program requirements, but you will not be eligible for the certification IPI offers. The scope of this certification DOES NOT include the investigational MDMA assisted-therapy protocol, or anything related to MAPS PBC’s educational content. There are no guarantees about FDA approval of MAPS PBC’s New Drug Application for investigational MDMA-assisted therapy or the specific certification requirements for healthcare providers should approval be granted.